5/7
08:49 am
vtgn
Vistagen to Present at the 2024 RBC Capital Markets Global Healthcare Conference [Yahoo! Finance]
Low
Report
Vistagen to Present at the 2024 RBC Capital Markets Global Healthcare Conference [Yahoo! Finance]
5/7
08:30 am
vtgn
Vistagen to Present at the 2024 RBC Capital Markets Global Healthcare Conference
Low
Report
Vistagen to Present at the 2024 RBC Capital Markets Global Healthcare Conference
4/25
08:30 am
vtgn
Vistagen Announces Positive Results from Phase 2A Pilot Study of PH15 for Improvement of Psychomotor Impairment Caused by Mental Fatigue
Low
Report
Vistagen Announces Positive Results from Phase 2A Pilot Study of PH15 for Improvement of Psychomotor Impairment Caused by Mental Fatigue
4/24
10:47 am
vtgn
Vistagen Therapeutics: A Pipeline With Potential In Anxiety And Depression [Seeking Alpha]
Low
Report
Vistagen Therapeutics: A Pipeline With Potential In Anxiety And Depression [Seeking Alpha]
4/9
08:30 am
vtgn
Vistagen to Present at the 2024 Anxiety and Depression Association (ADAA) Conference
Medium
Report
Vistagen to Present at the 2024 Anxiety and Depression Association (ADAA) Conference
4/1
08:30 am
vtgn
Vistagen Initiates PALISADE-3 Phase 3 Study of Fasedienol for the Acute Treatment of Social Anxiety Disorder Following Positive Results of PALISADE-2
Medium
Report
Vistagen Initiates PALISADE-3 Phase 3 Study of Fasedienol for the Acute Treatment of Social Anxiety Disorder Following Positive Results of PALISADE-2
3/20
09:04 pm
vtgn
Vistagen Therapeutics: Initial Analysis Of Fasedienol Points To Bullish [Seeking Alpha]
Low
Report
Vistagen Therapeutics: Initial Analysis Of Fasedienol Points To Bullish [Seeking Alpha]
3/17
03:16 am
vtgn
Why VistaGen Therapeutics Is A Buy: Fasedienol Potential For Anxiety Treatments [Seeking Alpha]
Low
Report
Why VistaGen Therapeutics Is A Buy: Fasedienol Potential For Anxiety Treatments [Seeking Alpha]
2/13/2024
04:20 pm
VTGN
vistagen therapeutics, inc.
BEAT
Report
5.1%
vistagen therapeutics, inc.
4/26
06:05 am
vtgn
Form 8-K Vistagen Therapeutics, For: Apr 25
Low
Report
Form 8-K Vistagen Therapeutics, For: Apr 25
4/16
06:04 am
vtgn
Form DEF 14A Vistagen Therapeutics, For: May 29
Low
Report
Form DEF 14A Vistagen Therapeutics, For: May 29
4/5
05:30 pm
vtgn
Form PRE 14A Vistagen Therapeutics, For: May 29
Low
Report
Form PRE 14A Vistagen Therapeutics, For: May 29
4/1
05:25 pm
vtgn
Form 8-K Vistagen Therapeutics, For: Apr 01
Low
Report
Form 8-K Vistagen Therapeutics, For: Apr 01
3/6
06:01 pm
vtgn
Form 4 Vistagen Therapeutics, For: Mar 04 Filed by: Cunningham Ann Michelle
Medium
Report
Form 4 Vistagen Therapeutics, For: Mar 04 Filed by: Cunningham Ann Michelle
3/6
06:01 pm
vtgn
Form 4 Vistagen Therapeutics, For: Mar 04 Filed by: Rotunno Mary L.
Medium
Report
Form 4 Vistagen Therapeutics, For: Mar 04 Filed by: Rotunno Mary L.
3/6
06:01 pm
vtgn
Form 4 Vistagen Therapeutics, For: Mar 04 Filed by: FitzPatrick Margaret M
Medium
Report
Form 4 Vistagen Therapeutics, For: Mar 04 Filed by: FitzPatrick Margaret M
3/6
06:01 pm
vtgn
Form 4 Vistagen Therapeutics, For: Mar 04 Filed by: GIN JERRY B
Medium
Report
Form 4 Vistagen Therapeutics, For: Mar 04 Filed by: GIN JERRY B
News Stats
All News
News Wires
Media Monitoring
SEC Edgar Filings
Upgrades
Downgrades
Initiated
Reiterated
Last Earnings
Last Earnings EPS
Next Earnings
Order Stats
Sub-Penny
Odd lot
Avg. bid-ask spread
Avg. bid-ask size
Shares at ask/bid
Off exchange
Main News & Impact Reports
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below:
Register